{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:36:03Z","timestamp":1770791763581,"version":"3.50.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jdcr.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T05:44:30Z","timestamp":1528263870000},"page":"543-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Drug-induced sarcoidosis in a patient treated with an interleukin-1 receptor antagonist for hidradenitis suppurativa"],"prefix":"10.1016","volume":"4","author":[{"given":"Blake E.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Joseph C.","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2018.03.007_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/rheumatology\/kes377","article-title":"Sarcoid-like granulomatosis in a patient treated by interleukin-1 receptor antagonist for TNF-receptor-associated periodic syndrome","volume":"52","author":"Sacre","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jdcr.2018.03.007_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2015.03.015","article-title":"Granulomatous drug eruptions","volume":"33","author":"Dodiuk-Gad","year":"2015","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jdcr.2018.03.007_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jdcr.2018.03.007_bib4","doi-asserted-by":"crossref","first-page":"e000239","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.jdcr.2018.03.007_bib5","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/jdv.13246","article-title":"TNF- \u03b1: a treatment target or cause of sarcoidosis?","volume":"29","author":"Amber","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jdcr.2018.03.007_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1590\/1806-9282.62.08.718","article-title":"Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept","volume":"62","author":"Vieira","year":"2016","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.jdcr.2018.03.007_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12890-016-0193-5","article-title":"Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapy","volume":"16","author":"Numakura","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"6 Suppl 1","key":"10.1016\/j.jdcr.2018.03.007_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1590\/abd1806-4841.20132487","article-title":"Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab\u2014a paradoxical effect? A case report","volume":"88","author":"Santos","year":"2013","journal-title":"An Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2018.03.007_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","author":"Cotliar","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jdcr.2018.03.007_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2018.03.007_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000439400","article-title":"Sarcoidosis in patients treated with Vemurafenib for metastatic melanoma: a paradoxical autoimmune activation","volume":"231","author":"Lheure","year":"2015","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jdcr.2018.03.007_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000161122","article-title":"Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient","volume":"218","author":"Eckert","year":"2009","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jdcr.2018.03.007_bib13","first-page":"315","article-title":"Cutaneous sarcoidosis in a patient with severe asthma treated with omalizumab","volume":"22","author":"Yung","year":"2015","journal-title":"Can Respir J"},{"issue":"12","key":"10.1016\/j.jdcr.2018.03.007_bib14","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1468-3083.2009.03249.x","article-title":"Cutaneous sarcoidosis associated with cosmetic fillers","volume":"23","author":"Izikson","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdcr.2018.03.007_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1503\/cmaj.150572","article-title":"Cutaneous sarcoidosis at insulin injection sites","volume":"188","author":"Zargham","year":"2016","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.jdcr.2018.03.007_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2230.1989.tb00938.x","article-title":"Zinc-induced granuloma\u2014a unique complication of insulin therapy","volume":"14","author":"Jordaan","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdcr.2018.03.007_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00105-015-3651-8","article-title":"Cutaneous granulomatous reactions at botulinum neurotoxin A injection sites: first manifestation of systemic sarcoidosis","volume":"66","author":"Herbert","year":"2015","journal-title":"Hautarzt"},{"issue":"2","key":"10.1016\/j.jdcr.2018.03.007_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2230.2007.02571.x","article-title":"Subcutaneous sarcoidosis localized to sites of previous desensitizing injections","volume":"33","author":"Marcoval","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2018.03.007_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00000372-199804000-00013","article-title":"Sarcoidal foreign-body granulomatous dermatitis associated with ophthalmic drops","volume":"20","author":"Carlson","year":"1998","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.jdcr.2018.03.007_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdcr.2016.12.004","article-title":"Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline","volume":"3","author":"Abbot","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2018.03.007_bib21","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jdcr.2018.03.007_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cmi.2016.25","article-title":"Clash of the cytokine titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses","volume":"14","author":"Mayer-Barber","year":"2017","journal-title":"Cell Mol Immunol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512618300717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512618300717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:18:41Z","timestamp":1762474721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512618300717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2352512618300717"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2018.03.007","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced sarcoidosis in a patient treated with an interleukin-1 receptor antagonist for hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}